ArticleFrontiers in pharmacology2022

Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.